- August 14, 2025
- August 14, 2025
Pharmacists’ Knowledge Gaps on Kratom: Building Competence for Patient Counseling
Pharmacists explore kratom’s potential benefits and risks, emphasizing the need for education on its effects, safety, and patient guidance.
- August 14, 2025
Understanding FDA Terms for Possible New Therapies to Prevent and Treat Diseases
The FDA is responsible for protecting public health by ensuring the safety and effectiveness of drugs, biologics and medical devices.…
- August 14, 2025
Patient Perceptions Support Co-Management of Chronic Kidney Disease
A collaborative care model enhances education and management for patients with chronic kidney disease, improving outcomes and understanding.
- August 14, 2025
Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome
Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.
- August 14, 2025
Overcoming Barriers in mCRC: Access, Adherence, and the Patient Voice
Panelists discuss how common barriers to implementing trifluridine/tipiracil plus bevacizumab combination therapy include complex pill burden management with multiple bottle…
- August 14, 2025
Gaps in CML Treatment in Underserved Populations
A panelist discusses how social determinants of health including low health literacy, economic instability, housing and transportation issues create significant…
- August 14, 2025
Smart Sequencing and Real-World Dosing in mCRC
Panelists discuss how real-world dose adjustment decisions in metastatic colorectal cancer are primarily driven by individual patient factors rather than…
- August 14, 2025
1052: The Best and the Worst Antiemetics in the ED
Show notes at pharmacyjoe.com/episode1052. In this episode, I’ll discuss the most effective and safest therapies for nausea/emesis in adult patients…
- August 13, 2025
KRAS-Targeted Vaccine Shows Durable Immune Responses, Survival Benefits in Pancreatic Colorectal Cancers
Elicio Therapeutics’ ELI-002 2P cancer vaccine shows promising survival benefits in pancreatic and colorectal cancer patients, enhancing immune responses.